Mediwound Ltd
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | -183.2% | – | – | – | – | – | |
| – | +36.2% | +25.8% | +46.4% | +2.2% | +17.1% | -3.7% | +1.8% | +99.1% | -5.1% | +13.6% | +2.7% | +2.4% | +13.8% | +15.3% | |
| – | -39.8% | +59.0% | +809.0% | -44.9% | +19.3% | -57.0% | -52.7% | +91.3% | +7.1% | +26.6% | +16.3% | -0.3% | +61.8% | -1.0% | |
| – | – | – | -77.7% | +35.5% | -107.7% | – | -252.4% | – | – | +154.3% | +323.1% | – | – | – | |
| – | -599.5% | – | – | -56.3% | +620.7% | -223.4% | – | – | -101.4% | – | -4,571.6% | – | -45.6% | +275.4% | |
| – | -51.4% | -13.3% | +10.6% | +2.5% | +72.7% | +53.4% | -50.3% | +48.3% | +16.5% | -47.0% | +13.5% | +1,064.7% | -3.0% | -12.2% | |
| – | -87.9% | +601.5% | +1,201.4% | – | -95.0% | -75.9% | -3,999.3% | -59.5% | – | -79.6% | -113.6% | +7,035.3% | -75.5% | +132.7% | |
| – | – | – | +348.6% | -100.0% | -73.1% | +323,685.7% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | +0.0% | +0.0% | +0.0% | -19.4% | +36.4% | +1.2% | – | – | – | |
| – | -75.7% | +988.3% | +276.7% | -98.9% | +16.6% | +2,435.3% | -99.8% | -2,287.0% | -37.5% | +66.9% | – | -35.9% | -15.4% | +52.7% | |
| – | -456.0% | – | +173.5% | -7.0% | -179.8% | – | -507.5% | – | +1,826.6% | -162.5% | – | -196.4% | – | – | |
| – | – | – | – | – | – | – | – | – | -204.3% | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.